Page last updated: 2024-09-05

tbc-11251 and Anasarca

tbc-11251 has been researched along with Anasarca in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Safdar, Z1

Other Studies

1 other study(ies) available for tbc-11251 and Anasarca

ArticleYear
Effect of transition from sitaxsentan to ambrisentan in pulmonary arterial hypertension.
    Vascular health and risk management, 2011, Volume: 7

    Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Drug Substitution; Dyspnea; Edema; Endothelin A Receptor Antagonists; Exercise Test; Exercise Tolerance; Familial Primary Pulmonary Hypertension; Female; Humans; Hypertension, Pulmonary; Isoxazoles; Liver Function Tests; Male; Middle Aged; Natriuretic Peptide, Brain; Oxygen; Phenylpropionates; Pyridazines; Retrospective Studies; Texas; Thiophenes; Time Factors; Treatment Outcome; Walking

2011